MiNK Therapeutics, Inc. announced that Jennifer Buell resigned as Agenus Inc.'s, President and Chief Operating Officer to become the President and Chief Executive Officer of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 USD | +15.61% |
|
+21.74% | +4.67% |
Jul. 01 | MiNK Therapeutics, Inc.(NasdaqCM:INKT) dropped from Russell Microcap Growth Index | CI |
Jul. 01 | MiNK Therapeutics, Inc.(NasdaqCM:INKT) dropped from Russell 3000E Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.67% | 44.09M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- INKT Stock
- News MiNK Therapeutics, Inc.
- MiNK Therapeutics, Inc. Announces Appointment of Jennifer Buell as Chief Executive Officer